Product Information
CEFIXIME 200 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $3.6836 per ML under NDC 68180040703. Its NADAC has been published 380 times since Oct 21, 2015.
FDA first approved this application on Apr 10, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040703
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA065355FDA Approved
4/10/2007
TE Code
AB
On Market Since
4/24/2015
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 200 MG/5 ML SUSP has been published 380 times since Oct 21, 2015, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6836 per ML |
|---|---|
| All-time high | $6.6362 (Feb 10, 2016) |
| All-time low | $2.8025 (Apr 17, 2024) |
| 52-week high | $5.6100 |
| 52-week low | $3.5799 |
| Median price | $5.6301 |
| Average price | $5.4842 |
| Largest weekly change | -42.4% (Apr 17, 2024) |
| Weeks tracked | 380 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFIXIME 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 200 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $3.6836 per ML (NDC 68180040703), effective Aug 19, 2026.
How has the price of CEFIXIME 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFIXIME 200 MG/5 ML SUSP has declined 42.3%. It has been tracked across 380 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for CEFIXIME 200 MG/5 ML SUSP?
Since Oct 21, 2015, the NADAC for CEFIXIME 200 MG/5 ML SUSP has ranged from a low of $2.8025 (Apr 17, 2024) to a high of $6.6362 (Feb 10, 2016), with a median of $5.6301 per ML.
Are there cheaper alternatives to CEFIXIME 200 MG/5 ML SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CEFIXIME 200 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFIXIME 200 MG/5 ML SUSP?
CEFIXIME 200 MG/5 ML SUSP (NDC 68180040703) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.